Viewing Study NCT06059118


Ignite Creation Date: 2025-12-25 @ 4:50 AM
Ignite Modification Date: 2026-04-24 @ 5:11 AM
Study NCT ID: NCT06059118
Status: RECRUITING
Last Update Posted: 2025-02-25
First Post: 2023-09-15
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Difluoromethylornithine and High Dose Testosterone With Enzalutamide in Metastatic Castration-Resistant Prostate Cancer
Sponsor: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module